Citadel Securities Reiterates a 'Neutral' on Salix Pharmaceuticals (SLXP); Moderately Adjusting Estimates
Tweet Send to a Friend
Citadel Securities reiterates a 'Neutral' on Salix Pharmaceuticals (NASDAQ: SLXP) price target of $40.00.
Citadel analyst says, "We are adjusting ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citadel analyst says, "We are adjusting ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
